We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
-$1.74B
Cap. Flow %
-0.79%
Top 10 Hldgs %
15.08%
Holding
8,767
New
733
Increased
3,708
Reduced
3,259
Closed
649

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.27%
2 Technology 8.11%
3 Financials 6.69%
4 Healthcare 6.3%
5 Consumer Discretionary 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHE
7051
Alterity Therapeutics
ATHE
$68.3M
$13K ﹤0.01%
1,011
+238
+31% +$4.14K
BCD icon
7052
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$445M
$13K ﹤0.01%
542
-279
-34% -$6.87K
BGI
7053
DELISTED
Birks Group
BGI
$13K ﹤0.01%
12,875
-2,625
-17% -$3.15K
CCLD icon
7054
CareCloud
CCLD
$94.8M
$13K ﹤0.01%
+3,484
New +$16.8K
CCM
7055
Concord Medical Services
CCM
$15.8M
$13K ﹤0.01%
361
+150
+71% +$5.33K
CMCM
7056
Cheetah Mobile
CMCM
$92.2M
$13K ﹤0.01%
418
-312
-43% -$12.4K
DOMO icon
7057
Domo
DOMO
$182M
$13K ﹤0.01%
650
-20,839
-97% -$368K
FTXN icon
7058
First Trust Nasdaq Oil & Gas ETF
FTXN
$164M
$13K ﹤0.01%
+808
New +$16.7K
GHYB icon
7059
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$137M
$13K ﹤0.01%
293
+14
+5% +$663
HDEF icon
7060
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.32B
$13K ﹤0.01%
637
-7,920
-93% -$174K
IMMP
7061
Immutep
IMMP
$47M
$13K ﹤0.01%
+6,925
New +$19.3K
JAGX icon
7062
Jaguar Health
JAGX
$1.14M
0
KPRX icon
7063
Kiora Pharmaceuticals
KPRX
$11.7M
$13K ﹤0.01%
5
+4
+400% +$9.23K
MFIN icon
7064
Medallion Financial
MFIN
$273M
$13K ﹤0.01%
2,828
-737
-21% -$4.51K
MGTX icon
7065
MeiraGTx Holdings
MGTX
$1.25B
$13K ﹤0.01%
1,357
+490
+57% +$6.18K
PPSI
7066
Pioneer Power Solutions
PPSI
$37.8M
$13K ﹤0.01%
2,515
+1,496
+147% +$7.72K
PVL
7067
Permianville Royalty Trust
PVL
$62M
$13K ﹤0.01%
7,048
-15,781
-69% -$42.8K
PY icon
7068
Principal Exchange-Traded Funds Principal Value ETF
PY
$245M
$13K ﹤0.01%
464
-1,498
-76% -$45.9K
RDHL
7069
Redhill Biopharma
RDHL
$3.62M
$13K ﹤0.01%
2
-5
-71% -$38.3K
ROSC icon
7070
Hartford Multifactor Small Cap ETF
ROSC
$59.4M
$13K ﹤0.01%
+481
New +$14K
SLGL icon
7071
Sol-Gel Technologies
SLGL
$211M
$13K ﹤0.01%
217
-129
-37% -$8.56K
DCOY
7072
Decoy Therapeutics
DCOY
$1.81M
0
TOVX icon
7073
Theriva Biologics
TOVX
$10.9M
$13K ﹤0.01%
95
+92
+3,067% +$21.8K
UXIN
7074
Uxin Ltd
UXIN
$240M
$13K ﹤0.01%
28
-24,252
-100% -$14M
VTGN icon
7075
VistaGen Therapeutics
VTGN
$10.4M
$13K ﹤0.01%
278
-92
-25% -$5.01K

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 733 new, 3,708 increased, 3,259 reduced and 649 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 733 new positions and closed 649 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.